Arvinas Inc Revenue per Employee (ARVN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Arvinas Inc   (NASDAQ: ARVN)
 

Arvinas Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Arvinas Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,287,398, below the company average number of $483,700.
Within the Healthcare sector Employees of 268 other companies have achieved higher revenue per employee. While Arvinas Inc 's total ranking has deteriorated compared to the previous quarter from 577 to 2124. Arvinas Inc has 246 employees.


What is Sales per Employee Ratio?







ARVN Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 1014.73 % -91.74 % -83.95 % -59.08 % -70.72 %
Sales per Employee (TTM) $ 1,287,398 363,415 1,067,480 1,269,512 1,515,447
ARVN's Total Ranking # 2124 # 577 # 0 # 384 #
Seq. Revenue Change 1500.64 % 64.21 % -77.33 % 87.05 % -88.14 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 128
Healthcare Sector # 269
Overall Market # 2124

Revenue per Employee Statistics
High Average Low
$ 1,735,366 $ 483,700 $ 13,721
(Mar 31 2025)   (Sep 30 2018)



Financial Statements
Arvinas Inc 's Revenue MRQ $ 250 Millions Visit ARVN's Income Statement
Arvinas Inc 's Revenues TTM $ 317 Millions Visit ARVN's aggregate revenue growth
What are ARVN's Sales? Visit ARVN's Sales by Segment




Other Ratios
Arvinas Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ARVN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ARVN's Competitors
Revenue per Employee for ARVN's Suppliers
Revenue per Employee for ARVN's Customers

You may also want to know
ARVN's Sales Growth Rates ARVN's Pe Price to earnings ratio ARVN's Receivables Turnover Ratio ARVN's Stock Quote
ARVN's Net Income Growth Rates ARVN's Ps Price to Sales ratio ARVN's Sales per Employee ARVN's Asset Turnover Ratio
ARVN's Net Margin ARVN's Pb Price to Book ratio ARVN's Financial Strength Ratios ARVN's Dividend Payout Ratio
Date modified: 2026-08-14T08:34:14+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Protagonist Therapeutics inc   2,136,303.03 $ 281.992  Million 132 
Exelixis Inc   2,123,731.47 $ 2,435.920  Million 1,147 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Krystal Biotech Inc   1,493,166.10 $ 440.484  Million 295 
Acadia Pharmaceuticals Inc   1,426,870.93 $ 1,138.643  Million 798 
Madrigal Pharmaceuticals Inc   1,403,213.11 $ 1,283.940  Million 915 
Indivior Pharmaceuticals Inc   1,333,000.00 $ 1,333.000  Million 1,000 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.